Speaker illustration

Doctor Paul Clift

Queen Elizabeth Hospital Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Paul qualified in London in 1993 and following Cardiology Speciality training was appointed Consultant Cardiologist at Queen Elizabeth Hospital Birmingham (QEHB) in 2005. Paul was awarded his MD from University of London in 2000 for his work on endothelin and the cardiovascular response to hypoxia at the Royal Postgraduate Medical School, Hammersmith Hospital. His specialist interest is adult congenital heart disease and the unit in Birmingham is one of the largest in Europe, with large cohorts of adults with complex congenital heart defects. His specific interests are the Fontan circulation, pulmonary hypertension associated with congenital heart disease and hereditary aortopathy. He is a Honorary Senior Lecturer at the Institute for Cardiovascular Science, University of Birmingham Paul is the NIHR CRN National Cardiovascular Speciality Lead, chairs the Cardiovascular Expert Working Group for the National Casemix Office and is Clinical Lead for the Centre for Rare Diseases at QEHB.

Adult outcomes of complex pulmonary atresia, ventricular septal defect and major aortopulmonary collaterals following repair during childhood, a single centre experience

Event: ESC Congress 2022

Topic: Adult Congenital Heart Disease (ACHD)

Session: Estimating the life span in congenital heart disease


The efficacy and safety of macitentan in Fontan-palliated patients: results of the 52-week randomised, placebo-controlled RUBATO trial

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Focus on the pulmonary vascular bed


This platform is supported by

logo Novo Nordisk